THW News and Press, Tekla World Healthcare Fund Shares of Beneficial Interest From 10/31/18

The Wall Street Journal reports that the pace of biotech IPOs in on track for a near-record year, although many are riskier due to being in earlier stages of development. The public funding rush has been heavily influenced by the FDA's willingness to accelerate approval for promising drugs...

The FDA announces its Plant and Animal Biotechnology Innovation Action Plan aimed at supporting advances in the space while ensuring product safety. The plan focuses on three key priorities: More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness R...

The FDA has issued two guidance documents that it says should help make the drug development process more efficient. More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Trust, Tekla World Healthcare Fund, Healthcare stocks news, News on ETFs, ...

The past week or so has certainly been an ugly one for stock investors as the market has declined by 5.18% since Monday's open (using SPY as a proxy for the market). There is certainly cause to believe that we have not seen the end of it yet as rising bond yields make that asset class increa...

Tekla World Healthcare Fund (NYSE: THW ) declares $0.1167/share monthly dividend , in line with previous. More news on: Tekla World Healthcare Fund, Dividend News, , Read more ...

By Evan McCulloch, Senior Vice President, Director of Research Franklin Equity Group ® Portfolio Manager, Franklin Biotechnology Discovery Fund Franklin Equity Group's Evan McCulloch explains why higher rates of drug utilization and healthcare spending are lending support to the b...